Stock Analysis on Net

AbbVie Inc. (NYSE:ABBV)

$24.99

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

AbbVie Inc., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in millions

Microsoft Excel
Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Short-term borrowings
Current portion of long-term debt and finance lease obligations
Accounts payable and accrued liabilities
Current liabilities
Long-term debt and finance lease obligations, excluding current portion
Deferred income taxes
Other long-term liabilities
Long-term liabilities
Total liabilities
Common stock, $0.01 par value
Common stock held in treasury, at cost
Additional paid-in-capital
Retained earnings (accumulated deficit)
Accumulated other comprehensive loss
Stockholders’ equity (deficit)
Noncontrolling interest
Total equity (deficit)
Total liabilities and equity (deficit)

Based on: 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).


Short-term Borrowings
The short-term borrowings exhibit significant volatility throughout the periods, remaining mostly low until a sharp spike in 2025, with values reaching 1,593 million US$ in March 2025 and further increasing to 5,556 million US$ in June 2025 before slightly declining. This pattern suggests a notable increase in reliance on short-term debt towards the end of the timeline.
Current Portion of Long-term Debt and Finance Lease Obligations
This item also reflects considerable fluctuation. After a peak in December 2020 (8,468 million US$), amounts generally trend downward with interim increases, then sharply rise again in 2024, peaking around 12,586 million US$ in June 2024 and then decreasing towards the end of 2025. The trend indicates periodic refinancing or shifting of long-term debt into current liabilities.
Accounts Payable and Accrued Liabilities
Accounts payable and accrued liabilities steadily increase from 12,709 million US$ in March 2020 to a peak of 33,619 million US$ by September 2025. Although some fluctuations occur, the overall trend suggests a rising level of payables and accrued expenses over time, potentially reflecting increased operational activity or longer payment cycles.
Current Liabilities
The total current liabilities increase from 16,471 million US$ in March 2020 to a maximum of 43,062 million US$ in March 2024, followed by a moderate decline and stabilization around high-39,000 million US$ in 2025. This is consistent with the trends observed in short-term borrowings, current portions of long-term debt, and payables.
Long-term Debt and Finance Lease Obligations (Excluding Current Portion)
Long-term debt remains elevated throughout the period, starting at 63,284 million US$ in March 2020 and displaying a declining trend until late 2023, followed by an increase around 2024 and 2025, reaching approximately 62,971 million US$ in September 2025. This pattern suggests active management of long-term liabilities with some periods of debt reduction and accumulation.
Deferred Income Taxes
Deferred income taxes decrease from 959 million US$ in March 2020, peaking in June 2020 at 4,785 million US$, then generally decline with some minor oscillations, stabilizing near 2,480 million US$ by September 2025. The reduction may indicate changes in taxable timing differences or tax strategies.
Other Long-term Liabilities
Other long-term liabilities maintain an upward trajectory, increasing from 17,900 million US$ to over 32,000 million US$ during the span, with intermittent fluctuations. This steady increase points to growing obligations or accruals classified as long-term liabilities.
Long-term Liabilities
The total long-term liabilities first increase sharply from 82,143 million US$ in March 2020 to over 110,000 million US$ by mid-2020 and then gradually decline before rising again toward late 2024 and 2025. The fluctuations appear correlated with movements in long-term debt and other long-term liabilities.
Total Liabilities
Total liabilities peak around 137,468 million US$ in December 2020 and gradually decline to just over 121,000 million US$ by late 2022, thereafter fluctuating upward to about 137,320 million US$ in mid-2025 before slightly dipping by the final period. This denotes active balance sheet management with periodic debt restructuring and liability adjustment.
Common Stock and Treasury Stock
The common stock par value remains stable at 18 million US$. Conversely, the value of common stock held in treasury is notably negative and expands over time from about -25,110 million US$ in March 2020 to around -9,143 million US$ in September 2025, suggesting ongoing stock repurchase activity and accumulation of treasury shares.
Additional Paid-in Capital
There is a consistent increase in additional paid-in capital from approximately 15,401 million US$ to 22,291 million US$, indicating ongoing capital contributions or stock issuance above par value.
Retained Earnings (Accumulated Deficit)
A declining trend is evident in retained earnings, moving from a positive balance of 5,973 million US$ in early 2020 into increasingly negative territory reaching -14,234 million US$ by September 2025. This suggests continued net losses or substantial dividend payments exceeding earnings over time.
Accumulated Other Comprehensive Loss
This item remains negative throughout the period with some fluctuations but no material directional trend, varying between approximately -1,538 million US$ and -3,697 million US$. This reflects ongoing negative impacts from foreign currency translation, pension adjustments, or other comprehensive loss components.
Stockholders’ Equity (Deficit) and Total Equity (Deficit)
Stockholders’ equity transitions from a deficit of -7,415 million US$ in March 2020 to positive territory around 16,283 million US$ by early 2022. After peaking, equity begins declining and turns negative again by mid-2025, reaching about -2,642 million US$. Total equity follows a similar pattern, evidencing variability and eventual erosion of shareholder value towards the end of the period.
Noncontrolling Interest
Noncontrolling interest modestly increases from 24 million US$ to a range near 40 million US$, showing minor growth over the reporting horizon and a limited impact on overall equity.
Total Liabilities and Equity (Deficit)
This aggregate metric remains relatively stable, peaking near 150,565 million US$ in late 2020, then declining gradually to about 133,898 million US$ by September 2025. Changes primarily reflect fluctuations in liabilities and equity components described above.